Dengue Testing Market Analysis

The dengue testing market is segmented on the basis of test type into ELISA-based test, RT-PCR amplification assay, dengue IgG/IgM rapid test, and others, out of which the ELISA-based test segment is anticipated to grab the largest share by the end of 2030 on account of its increasing adoption by end-users for diagnosing dengue. In addition, ELISA-based tests are used for the qualitative detection of dengue virus IgM antibodies and are considered to possess greater sensitivity in detecting dengue, which is also projected to contribute to the growth of the segment during the forecast period. Furthermore, based on end-user, the diagnostic centers segment in the global dengue testing market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that most of the dengue treatments are home-based ascribing to the development of an only mild form of illness. Thus, individuals prefer diagnostic centers for dengue testing.

Our in-depth analysis of the global market includes the following segments:

Test Type	ELISA-Based Test RT-PCR Amplification Assay Dengue IgG/IgM Rapid Test Others
End-User	Medical Hospitals Diagnostic Centers Others

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of dengue testing is evaluated at USD 667.34 million.

Dengue Testing Market size was over USD 635.8 million in 2023 and is poised to cross USD 1.38 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036. The growing incidences of dengue-related infections and the development of low-cost and reliable testing kits will fuel the market growth.

Asia Pacific is poised to account for largest revenue share by 2036, owing to high prevalence of dengue virus infections in several countries of the region such as Malaysia, Philippines and Vietnam, and the increase in government expenditure on improving healthcare infrastructure along with growing emphasis on carrying out dengue awareness campaigns in the region.

The major players in the market include Abbott Laboratories, InBios International, Inc., EUROIMMUN AG, and CERTEST BIOTEC SL, among others.

Dengue Testing Market Analysis